These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9782023)

  • 1. Cost-effectiveness in the management of patients with oesophageal cancer.
    Farndon MA; Wayman J; Clague MB; Griffin SM
    Br J Surg; 1998 Oct; 85(10):1394-8. PubMed ID: 9782023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases.
    Durand-Zaleski I; Earlam S; Fordy C; Davies M; Allen-Mersh TG
    Cancer; 1998 Sep; 83(5):882-8. PubMed ID: 9731890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural course of inoperable esophageal cancer treated with metallic expandable stents: quality of life and cost-effectiveness analysis.
    Xinopoulos D; Dimitroulopoulos D; Moschandrea I; Skordilis P; Bazinis A; Kontis M; Paraskevas I; Kouroumalis E; Paraskevas E
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1397-402. PubMed ID: 15610314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost consequences analysis of local corticosteroid injection and physiotherapy for the treatment of new episodes of unilateral shoulder pain in primary care.
    James M; Stokes EA; Thomas E; Dziedzic K; Hay EM
    Rheumatology (Oxford); 2005 Nov; 44(11):1447-51. PubMed ID: 16091398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study.
    McInnes G; Burke TA; Carides G
    J Hum Hypertens; 2006 Jan; 20(1):51-8. PubMed ID: 16357874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
    Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
    Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
    McKenna C; Bojke L; Manca A; Adebajo A; Dickson J; Helliwell P; Morton V; Russell I; Torgerson D; Watson J
    Rheumatology (Oxford); 2009 May; 48(5):558-63. PubMed ID: 19258378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer.
    O'Donnell CA; Fullarton GM; Watt E; Lennon K; Murray GD; Moss JG
    Br J Surg; 2002 Aug; 89(8):985-92. PubMed ID: 12153622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is a chest pain observation unit likely to be cost effective at my hospital? Extrapolation of data from a randomised controlled trial.
    Goodacre S; Dixon S
    Emerg Med J; 2005 Jun; 22(6):418-22. PubMed ID: 15911949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic evaluation of three physiotherapy treatments for non-specific neck disorders alongside a randomized trial.
    Lewis M; James M; Stokes E; Hill J; Sim J; Hay E; Dziedzic K
    Rheumatology (Oxford); 2007 Nov; 46(11):1701-8. PubMed ID: 17956916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
    Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
    Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between smoking during pregnancy and hospital inpatient costs in childhood.
    Petrou S; Hockley C; Mehta Z; Goldacre M
    Soc Sci Med; 2005 Mar; 60(5):1071-85. PubMed ID: 15589675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of two physiotherapy interventions for primary care back and neck pain patients: cost effectiveness analysis.
    Manca A; Dumville JC; Torgerson DJ; Klaber Moffett JA; Mooney MP; Jackson DA; Eaton S
    Rheumatology (Oxford); 2007 Sep; 46(9):1495-501. PubMed ID: 17711873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost determinants in aggressive non-Hodgkin's lymphoma.
    van Agthoven M; Sonneveld P; Verdonck LF; Uyl-de Groot CA
    Haematologica; 2005 May; 90(5):661-71. PubMed ID: 15921381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of an early intervention versus a conservative strategy in acute coronary syndrome.
    Epstein DM; Sculpher MJ; Clayton TC; Henderson RA; Pocock SJ; Buxton MJ; Fox KA
    Int J Cardiol; 2008 Jul; 127(2):240-6. PubMed ID: 17707103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.
    Henriksson M; Epstein DM; Palmer SJ; Sculpher MJ; Clayton TC; Pocock SJ; Henderson RA; Buxton MJ; Fox KA
    Heart; 2008 Jun; 94(6):717-23. PubMed ID: 18032459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating indirect costs in primary Sjögren's syndrome.
    Bowman SJ; St Pierre Y; Sutcliffe N; Isenberg DA; Goldblatt F; Price E; Hamburger J; Richards A; Rauz S; Regan M; Rigby S; Jones A; Mulherin D; Clarke AE
    J Rheumatol; 2010 May; 37(5):1010-5. PubMed ID: 20360188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cost effectiveness of services for early diagnosis and intervention in dementia.
    Banerjee S; Wittenberg R
    Int J Geriatr Psychiatry; 2009 Jul; 24(7):748-54. PubMed ID: 19206079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.